Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A larger reconstitution volume spreads the same material over more aliquots, which extends the period the solution sits in storage
It is the first dual GIP / GLP-1 receptor agonist approved by the FDA (Mounjaro 2022, Zepbound 2023) and serves as the reference compound for the broader class of multi-incretin analogs
By activating GLP-1 receptors, Semaglutide helps regulate blood sugar levels, reduce hunger, slow down the absorption of nutrients, and improve insulin sensitivity, all while promoting sustainable weight loss
The dosage is usually increased gradually, with the initial starting dose being 3 mg, then increasing to 7 mg after 30 days
Rest of EU delivery within 7-10 working days
US$ 27.34
US$ 20.11
US$ 27.92
US$ 26.63
US$ 26.20
